These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4150921)

  • 21. Inhibition of isoproterenol activation of adenylate cyclase by metoprolol, oxprenolol, and the para isomer of oxprenolol.
    Petrack B; Czernik AJ
    Mol Pharmacol; 1976 Mar; 12(2):203-7. PubMed ID: 4723
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 23. Differentiation of metabolic adrenoceptors.
    Loakpradit T; Lockwood R
    Br J Pharmacol; 1977 Jan; 59(1):135-40. PubMed ID: 13899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type.
    Erez M; Shtacher G; Weinstock M
    J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological properties of new 1,2-benzisothiazolyloxypropanolamines on cardiac and tracheal beta-receptors.
    Barocelli E; Chiavarini M; Ballabeni V; Mingiardi MR; Morini G; Ronchini F; Impicciatore M
    Boll Soc Ital Biol Sper; 1992 Jul; 68(7):445-51. PubMed ID: 1362354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative partial agonist activity of -adrenoceptor antagonists.
    Nayler WG
    Br J Pharmacol; 1972 Jun; 45(2):382-4. PubMed ID: 4403104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.
    Harry JD; Linden RJ; Snow HM
    Br J Pharmacol; 1974 Oct; 52(2):275-81. PubMed ID: 4155991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The selectivity of beta-adrenoceptor antagonists on isoprenaline-induced changes in heart rate, blood pressure, soleus muscle contractility and airways function in anaesthetized cats.
    Letts LG; Richardson DP; Temple DM; Williams LR
    Br J Pharmacol; 1983 Oct; 80(2):323-34. PubMed ID: 6140058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac beta-adrenoceptor blockade: the quest for selectivity.
    Barrett AM
    J Pharmacol; 1985; 16 Suppl 2():95-108. PubMed ID: 2867254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of beta-adrenoceptor blocking drugs, physostigmine, and atropine on the toxicity of doxepin in mice.
    Elonen E
    Med Biol; 1975 Aug; 53(4):231-7. PubMed ID: 241887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 32. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
    Krawietz W; Weinsteiger M; Pruchniewski M; Erdmann E
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():414-5. PubMed ID: 26149
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
    Dubach UC
    Schweiz Rundsch Med Prax; 1975 Sep; 64(39):1239-41. PubMed ID: 241073
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-adrenoceptor blocking agents and responses to adrenaline and 5-hydroxytryptamine in rat isolated stomach and uterus.
    Schechter Y; Weinstock M
    Br J Pharmacol; 1974 Oct; 52(2):283-7. PubMed ID: 4155992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 38. Blockade of peripheral vascular responses to isoprenaline by three beta-adrenoceptor antagonists in the anaesthetized dog.
    Hainsworth R; Karim F; Stoker JB
    Br J Pharmacol; 1974 Jun; 51(2):161-8. PubMed ID: 4155969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.